PHARM logo

Pharmiva AB (publ) Stock Price

OM:PHARM Community·SEK 9.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

PHARM Share Price Performance

SEK 0
0.00 (0.00%)
SEK 0
0.00 (0.00%)
Price SEK 0

PHARM Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet and slightly overvalued.

5 Risks
0 Rewards

Pharmiva AB (publ) Key Details

SEK 4.3m

Revenue

SEK 1.7m

Cost of Revenue

SEK 2.6m

Gross Profit

SEK 24.0m

Other Expenses

-SEK 21.4m

Earnings

Last Reported Earnings
Jun 30, 2023
Next Reporting Earnings
n/a
-1.23
61.22%
-502.51%
0%
View Full Analysis

About PHARM

Founded
2015
Employees
5
CEO
Anna Linton
WebsiteView website
www.pharmiva.com

Pharmiva AB (publ) engages in the research and development of medical products in Sweden. The company offers Vernivia, an over-the-counter vaginal mousse for the treatment of bacterial vaginosis. The company was incorporated in 2015 and is headquartered in Lund, Sweden.

Recent PHARM News & Updates

Recent updates

No updates